ROYCE & ASSOCIATES LP - CUBIST PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CUBIST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$13,134,000
-11.1%
197,980
-6.4%
0.04%0.0%
Q2 2014$14,774,000
-8.2%
211,600
-3.8%
0.04%
-8.3%
Q1 2014$16,086,000
-24.1%
219,900
-28.6%
0.05%
-21.3%
Q4 2013$21,198,000
-21.7%
307,800
-27.7%
0.06%
-23.8%
Q3 2013$27,060,000
+70.7%
425,800
+29.7%
0.08%
+63.3%
Q2 2013$15,852,000328,2000.05%
Other shareholders
CUBIST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AKANTHOS CAPITAL MANAGEMENT LLC 50,500$3,526,00010.49%
Palo Alto Investors LP 1,526,916$106,609,0007.94%
HealthCor Management, L.P. 1,225,000$85,530,0004.29%
SECTOR GAMMA AS 192,490$13,440,0003.18%
AMI ASSET MANAGEMENT CORP 363,698$25,393,0002.52%
EAGLE BOSTON INVESTMENT MANAGEMENT INC 578,207$40,370,0002.01%
TURNER INVESTMENTS LLC 559,239$39,046,0001.73%
Tekla Capital Management LLC 263,772$18,417,0001.69%
MAZAMA CAPITAL MANAGEMENT INC 80,221$5,601,0001.50%
WESTFIELD CAPITAL MANAGEMENT CO LP 3,234,570$225,838,0001.34%
View complete list of CUBIST PHARMACEUTICALS INC shareholders